Dolby Laboratories (DLB) Stock Price, News & Analysis

Company Overview

Dolby Laboratories, Inc. develops and licenses audio and imaging technologies designed to enhance entertainment and communications experiences. The company’s solutions are used in cinemas, home theaters, televisions, mobile devices, personal computers, automobiles, broadcast systems and streaming services.

Its principal technologies include Dolby Atmos, an immersive audio format, and Dolby Vision, a high-dynamic-range imaging technology. Dolby also offers technologies for digital audio encoding and playback, voice and communications applications, and cinema sound systems. The company works with content creators, studios, broadcasters, streaming providers, device manufacturers and other technology companies to support the creation, distribution and playback of Dolby-enabled content.

Founded by engineer Ray Dolby in 1965, Dolby Laboratories serves customers and partners internationally through a business model centered on technology development, certification and licensing. The company is headquartered in San Francisco, California, and has been led by President and Chief Executive Officer Kevin Yeaman since 2013.

Key Stats

• Today's Range: $57.84 to $59.97
• 50-Day Range: $48.97 to $66.27
• 52-Week Range: $48.26 to $73.01
• Volume: 1.32 million shs
• Average Volume: 855,497 shs
• Market Capitalization: $5.45 billion
• P/E Ratio: 24.77
• Dividend Yield: 2.47%
• Price Target: $87.50
• Consensus Rating: Moderate Buy

Dolby Laboratories Stock Analysis - MarketRank™

Dolby Laboratories scored higher than 91% of companies evaluated by MarketBeat, and ranked 67th out of 594 stocks in the technology sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 3.7 / 5
• Analyst Rating: Moderate Buy

Consensus Rating

Dolby Laboratories has received a consensus rating of Moderate Buy. The company's average rating score is 2.67, and is based on no strong buy ratings, 2 buy ratings, 1 hold rating, and no sell ratings.

Upside Potential

Dolby Laboratories has a consensus price target of $87.50, representing about 50.3% upside from its current price of $58.22.

Amount of Analyst Coverage

Dolby Laboratories has only been the subject of 2 research reports in the past 90 days.

Earnings and Valuation

• Score: 1.9 / 5
• Proj. Earnings Growth: 4.02%

Earnings Growth

Earnings for Dolby Laboratories are expected to grow by 4.02% in the coming year, from $3.23 to $3.36 per share.

Price to Earnings Ratio vs. the Market

The P/E ratio of Dolby Laboratories is 24.77, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 39.02.

Price to Earnings Ratio vs. Sector

The P/E ratio of Dolby Laboratories is 24.77, which means that it is trading at a less expensive P/E ratio than the Technology sector average P/E ratio of about 79.04.

Price to Book Value per Share Ratio

Dolby Laboratories has a P/B Ratio of 2.11. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

Short Interest

• Score: 3.0 / 5
• Short Interest Level: Healthy

Percentage of Shares Shorted

9.52% of the float of Dolby Laboratories has been sold short.

Short Interest Ratio / Days to Cover

Dolby Laboratories has a short interest ratio ("days to cover") of 5.53.

Change versus previous month

Short interest in Dolby Laboratories has recently decreased by 6.06%, indicating that investor sentiment is improving significantly.

Dividend

• Score: 4.2 / 5
• Dividend Strength: Strong

Dividend Yield

Dolby Laboratories pays a meaningful dividend of 2.51%, higher than the bottom 25% of all stocks that pay dividends.

Dividend Growth

Dolby Laboratories has been increasing its dividend for 10 years.

Dividend Coverage

The dividend payout ratio of Dolby Laboratories is 61.28%. This payout ratio is at a healthy, sustainable level, below 75%.

Dividend Sustainability

Based on earnings estimates, Dolby Laboratories will have a dividend payout ratio of 42.86% next year. This indicates that Dolby Laboratories will be able to sustain or increase its dividend.

News and Social Media

• Score: 1.5 / 5
• News Sentiment: N/A

News Sentiment

Dolby Laboratories has a news sentiment score of 0.41. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.54 average news sentiment score of Technology companies.

News Coverage This Week

MarketBeat has tracked 1 news article for Dolby Laboratories this week, compared to 4 articles on an average week.

Company Ownership

• Score: 2.1 / 5
• Insider Trading: Selling Shares

Insider Buying vs. Insider Selling

In the past three months, Dolby Laboratories insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $1,706,606.00 in company stock.

Percentage Held by Insiders

37.93% of the stock of Dolby Laboratories is held by insiders. A high percentage of insider ownership can be a sign of company health.

Percentage Held by Institutions

58.56% of the stock of Dolby Laboratories is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

Company Calendar

• Last Earnings: 7/30/2026
• Record date for 8/19 Dividend: 8/11/2026
• Ex-Dividend for 8/19 Dividend: 8/11/2026
• Dividend Payable: 8/19/2026
• Today: 9/23/2026
• Fiscal Year End: 9/30/2026
• Next Earnings (Estimated): 11/17/2026

Industry, Sector and Symbol

• Stock Exchange: NYSE
• Sector: Technology
• Industry: Software
• Sub-Industry: Systems Software
• Current Symbol: NYSE:DLB
• CIK: 1308547
• Web: www.dolby.com
• Phone: (415) 558-0200
• Fax: 415-645-4000
• Employees: 2,051
• Year Founded: 1965

Price Target and Rating

• Average Price Target for Dolby Laboratories: $87.50
• High Price Target: $90.00
• Low Price Target: $85.00
• Potential Upside/Downside: +50.3%
• Consensus Rating: Moderate Buy
• Rating Score (0-4): 2.67
• Research Coverage: 3 Analysts

Profitability

• EPS (Trailing Twelve Months): $2.35
• Trailing P/E Ratio: 24.77
• Forward P/E Ratio: 18.02
• P/E Growth: N/A
• Net Income: $255.02 million
• Net Margins: 16.70%
• Pretax Margin: 20.44%
• Return on Equity: 11.08%
• Return on Assets: 9.04%

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: 3.19
• Quick Ratio: 3.11

Sales & Book Value

• Annual Sales: $1.35 billion
• Price / Sales: 4.04
• Cash Flow: $4.33 per share
• Price / Cash Flow: 13.43
• Book Value: $27.56 per share
• Price / Book: 2.11

Miscellaneous

• Outstanding Shares: 93,670,000
• Free Float: 58,140,000
• Market Cap: $5.45 billion
• Optionable: Optionable
• Beta: 0.80